Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.
| Image |  |
|---|---|
| Description | scientific article published in September 2017 |
| Author/s |
author: Valerio Nardone Mariarosaria Boccellino Gabriella Misso Cristiana Bellan Marcella Barbarino Maria Grazia Cusi Cirino Botta Pierfrancesco Tassone Francesca Capone Piero Paladini Antonio Giordano Pierosandro Tagliaferri Pierpaolo Correale Michele Caraglia Giuseppe Battaglia |
| Publication date | September 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |